Immune Repertoire Sequencing Market Industry Insights, Size, Growth, Outlook and Forecast to 2026


Posted August 8, 2018 by abhijit

Immune repertoire sequencing is also widely applicable in biomarker discovery, infectious disease research, asthma and allergy research, and cancer immunotherapy.

 
Immune repertoire refers to the sub-type proteins an organism’s immune system creates. Immune systems in vertebrates have six key types of proteins namely: immunoglobulin (2) and T cell receptors (4). Immune repertoire sequencing enables researchers and scientist to examine and understand adaptive immune-mediated diseases. Immune repertoire sequencing is also widely applicable in biomarker discovery, infectious disease research, asthma and allergy research, and cancer immunotherapy.

Increasing research and development and launches of novel products by key players in market is expected to be the major driving force for growth of global immune repertoire sequencing market in the near future. For instance, in 2016, ArcherDX, Inc., a U.S.-based company, expanded its product portfolio with the launch of its latest Archer Immunoverse immune repertoire sequencing assays at the American Society of Hematology (ASH). In 2017, ArcherDX, Inc.

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1517

launched its latest Archer Immunoverse B Cell Receptor (BCR) assays to characterize the human B cell repertoire. In 2017, researchers from Stanford University applied immune repertoire sequencing to identify disease-related signatures in the immune systems of patients with systemic sclerosis with pulmonary hypertension (SSc-PAH), a rare chronic autoimmune disease that affects the connective tissue. Increasing research on immune repertoire sequencing is expected to create a conducive environment for growth of immune repertoire sequencing market in the near future. Recently, immune repertoire sequencing has been applied for the development of cancer biomarkers and immunotherapies. Therefore, increasing prevalence of cancer is expected to positively drive growth of immune repertoire sequencing market. For instance, according to the National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease.

Immune Repertoire Sequencing Market: Regional Analysis

North America is expected to hold a dominant position in global immune repertoire sequencing market, over the forecast period. This is owing to high presence of key players in the region. These players are increasingly focusing on development of novel technology for immune repertoire sequencing. For instance, Illumina Inc., Thermo Fisher Scientific, Pacific Biosciences, CD Genomics are the key players in the North America market. In 2017, a U.S.-based 10x Genomics Inc. added a new B-Cell and 5’unbiased enrichment kit to its chromium immune repertoire profiling solution or immune repertoire sequencing.

Immune Repertoire Sequencing Market: Key Players

Key players in global immune repertoire sequencing market include Thermo Fisher Scietific, Illumina Inc., ArcherDX, Inc., Roche Holding AG, Juno Therapeutics, Pacific Biosciences, CD Genomics, Atreca, Inc., and Adaptive Biotechnologies. Major players in the market are involved in strategic partnership and collaborations, in order to develop and provide immune repertoire sequencing services to customers. For instance, in March 2018, ArcherDX Inc. and Ambry Genetics entered into strategic partnership to provide immune repertoire sequencing services to biopharmaceutical customers.

Immune Repertoire Sequencing Market Taxonomy:

The global immune repertoire sequencing market is segmented on the basis of product type, application, end user, and region. By Product Type: Instruments, Reagents and Kits, By Application: Cancer Immunotherapy, Infectious Disease, Asthma And Allergy, Biomarker Discovery, Organ Transplant, Immune Response, Autoimmune Diseases, Others,. By End User: Diagnostic Labs, Biopharmaceutical Companies, Research Institutes, Others,. By Region: North America, Latin America, Europe, Asia Pacific, Middle East, Africa,.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mr.Shah
Website https://www.coherentmarketinsights.com/
Phone 12067016702
Business Address 1001 4th Ave,
#3200
Country United States
Categories Insurance , Outdoors , Pets
Tags immune repertoire sequencing market size , immune repertoire sequencing market , immune repertoire sequencing marketoutlook
Last Updated August 8, 2018